REDOSER project: optimising biological therapy dose for rheumatoid arthritis and spondyloarthritis patients
Background: Reducing the dose of biological therapy (BT) when patients with immune-mediated arthritis achieve a sustained therapeutic goal may help to decrease costs for national health services and reduce the risk of serious infection. However, there is little information about whether such a decis...
Main Authors: | Isidoro González-Álvaro, Antonio J. Blasco, Pablo Lázaro, Carlos Sánchez-Piedra, Raquel Almodovar, Javier Bachiller-Corral, Alejandro Balsa, Rafael Caliz, Gloria Candelas, Cristina Fernández-Carballido, Angel García-Aparicio, Blanca García-Magallón, Rosario García-Vicuña, Antonio Gómez-Centeno, Ana M. Ortiz, Raimon Sanmartí, Jesús Sanz, Beatriz Tejera |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-11-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844017310150 |
Similar Items
-
Risk of myocardial infarction with use of selected nonsteroidal anti-inflammatory drugs in spondyloarthritis patients
by: Dubreuil, Maureen
Published: (2017) -
Factors related to adherence of recommendations for redose administration in clean surgeries
by: Cristiane Schmitt, et al.
Published: (2015-03-01) -
Genetics, Epigenetics, and Gender Impact in Axial-Spondyloarthritis Susceptibility: An Update on Genetic Polymorphisms and Their Sex Related Associations
by: Maria Sole Chimenti, et al.
Published: (2021-08-01) -
Intraoperative Redosing of Cefazolin and Risk for Surgical Site Infection in Cardiac Surgery
by: Giorgio Zanetti, et al.
Published: (2001-10-01) -
Radionuclide Methods in the Diagnosis of Sacroiliitis in Patients with Spondyloarthritis: An Update
by: Karina Zilber, et al.
Published: (2016-10-01)